Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: Results of two phase III trials

Vincent Meininger, Gilbert Bensimon, Walter G. Bradley, Benjamin R. Brooks, Patrice Douillet, Andrew A. Eisen, Lucette Lacomblez, P. Nigel Leigh, Wim Robberecht

Research output: Contribution to journalArticlepeer-review

99 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: Results of two phase III trials'. Together they form a unique fingerprint.

Medicine & Life Sciences